The withdrawal of drugs from the market as a result of post-authorisation pharmacovigilance
Subject of study. Post-authorisation pharmacovigilance enables the continuous updating of knowledge about adverse effects of medicinal products used in everyday clinical practice. As a result, new information emerges that may change the current positive safety assessment of the drug and contributes...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Polish |
| Published: |
Polish Pharmaceutical Society
2022-08-01
|
| Series: | Farmacja Polska |
| Subjects: | |
| Online Access: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F6%2F01_OG_Leki_wycofane_n.pdf |